Form 4 for PRLD Prelude Therapeutics Inc
Accepted 2021-07-08 00:00:00 ET · period of report 2021-07-06 · accession 0001209191-21-046013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-08 | 2021-07-06 | PRLD | Mauro David J | Chief Medical Off | S - Sale+OE | $27.48 | -15.0K | 4,555 | -77% | -$412.1K |
| D | 2021-07-08 | 2021-07-06 | PRLD | Mauro David J | Chief Medical Off | M - OptEx | $1.89 | +15.0K | 15.0K | New | +$28.4K |
| D | 2021-07-08 | 2021-07-06 | PRLD | Mauro David J | Chief Medical Off | M - OptEx | $0.00 | -15.0K | 182.6K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-06 | S | D | 300 | $28.84 | 0 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.80 to $28.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
| 2 | Common | Common Stock | 2021-07-06 | S | D | 4,255 | $28.13 | 300 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.75 to $28.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
| 3 | Common | Common Stock | 2021-07-06 | M | A | 15,000 | $1.89 | 15,000 | D | — | — | |
| 4 | Common | Common Stock | 2021-07-06 | S | D | 10,445 | $27.17 | 4,555 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.74 to $27.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2021-07-06 | M | D | 15,000 | $0.00 | 182,610 | D | $1.89 · — to 2029-07-17 | 15,000 Common Stock | (F5) The stock option vested as to 25% of the total shares monthly on May 1, 2020, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date. |